124 related articles for article (PubMed ID: 38528341)
21. Clostridium thermocellum thermostable lichenase with circular permutations and modifications in the N-terminal region retains its activity and thermostability.
Tyurin AА; Sadovskaya NS; Nikiforova KhR; Mustafaev ON; Komakhin RA; Fadeev VS; Goldenkova-Pavlova IV
Biochim Biophys Acta; 2015 Jan; 1854(1):10-9. PubMed ID: 25448724
[TBL] [Abstract][Full Text] [Related]
22. Recombinant rat fibroblast growth factor-16: structure and biological activity.
Danilenko DM; Montestruque S; Philo JS; Li T; Hill D; Speakman J; Bahru M; Zhang M; Konishi M; Itoh N; Chirica M; Delaney J; Hernday N; Martin F; Hara S; Talvenheimo J; Narhi LO; Arakawa T
Arch Biochem Biophys; 1999 Jan; 361(1):34-46. PubMed ID: 9882426
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a biologically active extracellular domain of fibroblast growth factor receptor 1 expressed in Escherichia coli.
Bergonzoni L; Caccia P; Cletini O; Sarmientos P; Isacchi A
Eur J Biochem; 1992 Dec; 210(3):823-29. PubMed ID: 1336458
[TBL] [Abstract][Full Text] [Related]
24. Structure-based mutational analyses in FGF7 identify new residues involved in specific interaction with FGFR2IIIb.
Sher I; Yeh BK; Mohammadi M; Adir N; Ron D
FEBS Lett; 2003 Sep; 552(2-3):150-4. PubMed ID: 14527678
[TBL] [Abstract][Full Text] [Related]
25. Mutations uncouple human fibroblast growth factor (FGF)-7 biological activity and receptor binding and support broad specificity in the secondary receptor binding site of FGFs.
Sher I; Weizman A; Lubinsky-Mink S; Lang T; Adir N; Schomburg D; Ron D
J Biol Chem; 1999 Dec; 274(49):35016-22. PubMed ID: 10574979
[TBL] [Abstract][Full Text] [Related]
26. STRUCTURAL AND FUNCTIONAL CONSEQUENCES OF CIRCULAR PERMUTATION ON THE ACTIVE SITE OF OLD YELLOW ENZYME.
Daugherty AB; Horton JR; Cheng X; Lutz S
ACS Catal; 2015 Feb; 5(2):892-899. PubMed ID: 25692074
[TBL] [Abstract][Full Text] [Related]
27. Engineering of fibroblast growth factor: alteration of receptor binding specificity.
Seddon AP; Aviezer D; Li LY; Böhlen P; Yayon A
Biochemistry; 1995 Jan; 34(3):731-6. PubMed ID: 7827030
[TBL] [Abstract][Full Text] [Related]
28. Improved production of recombinant fibroblast growth factor 7 (FGF7/KGF) from bacteria in high magnesium chloride.
Luo Y; Cho HH; Jones RB; Jin C; McKeehan WL
Protein Expr Purif; 2004 Feb; 33(2):326-31. PubMed ID: 14711521
[TBL] [Abstract][Full Text] [Related]
29. Functional expression of recombinant human trefoil factor 1 by Escherichia coli and Brevibacillus choshinensis.
Cheng YM; Lu MT; Yeh CM
BMC Biotechnol; 2015 May; 15():32. PubMed ID: 25990322
[TBL] [Abstract][Full Text] [Related]
30. Biospecific extraction and neutralization of anticoagulant heparin with fibroblast growth factors (FGF).
Luo Y; Cho HH; McKeehan WL
J Pharm Sci; 2003 Oct; 92(10):2117-27. PubMed ID: 14502551
[TBL] [Abstract][Full Text] [Related]
31. Anabolic effect of aminoterminally truncated fibroblast growth factor 4 (FGF4) on bone.
Kuroda S; Kasugai S; Oida S; Iimura T; Ohya K; Ohyama T
Bone; 1999 Oct; 25(4):431-7. PubMed ID: 10511109
[TBL] [Abstract][Full Text] [Related]
32. An S116R Phosphorylation Site Mutation in Human Fibroblast Growth Factor-1 Differentially Affects Mitogenic and Glucose-Lowering Activities.
Xia X; Kumru OS; Blaber SI; Middaugh CR; Li L; Ornitz DM; Suh JM; Atkins AR; Downes M; Evans RM; Tenorio CA; Bienkiewicz E; Blaber M
J Pharm Sci; 2016 Dec; 105(12):3507-3519. PubMed ID: 27773526
[TBL] [Abstract][Full Text] [Related]
33. Control of fibroblast growth factor (FGF) 7- and FGF1-induced mitogenesis and downstream signaling by distinct heparin octasaccharide motifs.
Luo Y; Ye S; Kan M; McKeehan WL
J Biol Chem; 2006 Jul; 281(30):21052-21061. PubMed ID: 16728399
[TBL] [Abstract][Full Text] [Related]
34. Exosome-transmitted circ-CARD6 facilitates posterior capsule opacification development by miR-31/FGF7 axis.
Liu Y; Chen T; Zheng G
Exp Eye Res; 2021 Jun; 207():108572. PubMed ID: 33844960
[TBL] [Abstract][Full Text] [Related]
35. Scaling up production of recombinant human basic fibroblast growth factor in an
Li L; Yu B; Lai Y; Shen S; Yan Y; Dong G; Gao X; Cao Y; Ge C; Zhu L; Liu H; Tao S; Yao Z; Li S; Wang X; Hui Q
Front Pharmacol; 2023; 14():1279516. PubMed ID: 38375209
[No Abstract] [Full Text] [Related]
36. Tying up the loose ends: circular permutation decreases the proteolytic susceptibility of recombinant proteins.
Whitehead TA; Bergeron LM; Clark DS
Protein Eng Des Sel; 2009 Oct; 22(10):607-13. PubMed ID: 19622546
[TBL] [Abstract][Full Text] [Related]
37. Functional expression of a plant hydroxynitrile lyase in Escherichia coli by directed evolution: creation and characterization of highly in vivo soluble mutants.
Asano Y; Dadashipour M; Yamazaki M; Doi N; Komeda H
Protein Eng Des Sel; 2011 Aug; 24(8):607-16. PubMed ID: 21729945
[TBL] [Abstract][Full Text] [Related]
38. Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair.
Finch PW; Rubin JS
Adv Cancer Res; 2004; 91():69-136. PubMed ID: 15327889
[TBL] [Abstract][Full Text] [Related]
39. FGF7/KGF triggers cell transformation and invasion on immortalised human prostatic epithelial PNT1A cells.
Ropiquet F; Huguenin S; Villette JM; Ronflé V; Le Brun G; Maitland NJ; Cussenot O; Fiet J; Berthon P
Int J Cancer; 1999 Jul; 82(2):237-43. PubMed ID: 10389758
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a soluble KGF receptor cDNA from human corneal and breast epithelial cells.
Liu JJ; Shay JW; Wilson SE
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2584-93. PubMed ID: 9856768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
